Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 47.35
-0.15 (-0.32%)
Apr 17, 2026, 1:30 PM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 4.11 billion as of April 17, 2026. Its market cap has decreased by -5.86% in one year.
Market Cap
4.11B
Enterprise Value
6.35B
Revenue
4.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
47.35
Market Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 4.11B, an increase of 486.10%. That is a compound annual growth rate of 8.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 4.11B | 5.69% |
| Dec 31, 2025 | 3.89B | -7.05% |
| Dec 31, 2024 | 4.18B | 23.91% |
| Dec 29, 2023 | 3.37B | 7.46% |
| Dec 30, 2022 | 3.14B | -0.41% |
| Dec 30, 2021 | 3.15B | -24.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Laboratories | 6.34B |
| LIWANLI Innovation | 6.11B |
| SCI Pharmtech | 5.80B |
| Orient Pharma | 5.60B |
| Easywell Biomedicals | 5.15B |
| Merdury Biopharmaceutical | 3.39B |
| Maywufa Company | 2.90B |
| Allied Biotech | 2.65B |